AI Science Tracker
EN

Thermo Fisher Scientific

1 discovery from 2023

Discoveries

Cross-sectional Ct distributions from qPCR tests can provide an early warning signal for the spread of COVID-19 in communities

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Ct-derived epidemic trajectories were added to a deep-learning forecast and evaluated against observed cases at 7- and 14-day horizons, including prospective January–April 2022 testing; supports earlier signals and forecast-error improvement in the studied campus and county data, not general epidemic surveillance. Full Methods/Results were reviewed.

Technology: Full text Methods describe enhancing a deep-learning forecasting model with Ct-derived features and epidemic trajectories.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Full text Methods describe enhancing a deep-learning forecasting model with Ct-derived features and epidemic trajectories.
Limitation / still unknown
The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/articles/PMC10570742 · https://pubmed.ncbi.nlm.nih.gov/37841738/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.